Andrew John Eatherton

Person

Brentford, GB

People

Patents Grantslast 30 patents

Information Patent Grant
2-(benzyloxy) benzamides as LRRK2 kinase inhibitors
- Patent number 9,365,551
- Issue date Jun 14, 2016
- Glaxo Group Limited
- Daniele Andreotti
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds
- Patent number 8,778,939
- Issue date Jul 15, 2014
- Glaxo Group Limited
- Paula Louise Nichols
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrimidine derivatives and their use as CB2 modulators
- Patent number 7,635,701
- Issue date Dec 22, 2009
- Glaxo Group Limited
- Andrew John Eatherton
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrrolopyridine derivatives
- Patent number 7,589,206
- Issue date Sep 15, 2009
- Glaxo Group Limited
- Andrew John Eatherton
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
2-(BENZYLOXY) BENZAMIDES AS LRRK2 KINASE INHIBITORS
- Publication number 20130225584
- Publication date Aug 29, 2013
- Daniele Andreotti
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL COMPOUNDS
- Publication number 20120184553
- Publication date Jul 19, 2012
- Paula Louise Nichols
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BENZOFURAN COMPOUNDS USEFUL IN THE TREATMENT OF CONDITIONS MEDIATED...
- Publication number 20100056527
- Publication date Mar 4, 2010
- Glaxo Group Limited
- Andrew John Eatherton
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Pyrimidine Derivatives And Their Use As CB2 Modulators
- Publication number 20100041654
- Publication date Feb 18, 2010
- Andrew John Eatherton
- C07 - ORGANIC CHEMISTRY
Information Patent Application
2-(Phenylamino)-Pyrimidin-5-Amides As Cannabinoid 2 Receptors Modul...
- Publication number 20090264452
- Publication date Oct 22, 2009
- Andrew John Eatherton
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds
- Publication number 20090018128
- Publication date Jan 15, 2009
- Andrew John Eatherton
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Pyridine Derivatives and Their Use as Cb2 Receptor Modulators
- Publication number 20080280868
- Publication date Nov 13, 2008
- Andrew John Eatherton
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Pyrimidine Derivatives as Cannabinoid Receptor Modulators
- Publication number 20080261977
- Publication date Oct 23, 2008
- Andrew John Eatherton
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Imidazopyridine Derivatives as Cannabinoid Receptor Ligands
- Publication number 20080221097
- Publication date Sep 11, 2008
- Glaxo Group Limited
- Andrew John Eatherton
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Combination Of Cb2 Modulators And Pde4 Inhibitors For Use In Medicine
- Publication number 20080132505
- Publication date Jun 5, 2008
- Glaxo Group Limited
- Andrew James Brown
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Pyrrolopyridine Derivatives
- Publication number 20070219229
- Publication date Sep 20, 2007
- Glaxo Group Limited
- Andrew John Eatherton
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Pyridine derivatives as cb2 receptor modulators
- Publication number 20070129367
- Publication date Jun 7, 2007
- Andrew John Eatherton
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Pyrimidine derivatives and their use as CB2 modulators
- Publication number 20060293354
- Publication date Dec 28, 2006
- Glaxo Group Limited
- Andrew John Eatherton
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Pyrimidine compounds
- Publication number 20060247261
- Publication date Nov 2, 2006
- Andrew John Eatherton
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Pyridine derivatives as cb2 receptor modulators
- Publication number 20060240048
- Publication date Oct 26, 2006
- Andrew John Eatherton
- C07 - ORGANIC CHEMISTRY

Andrew John Eatherton

Person

Patents Grantslast 30 patents

2-(benzyloxy) benzamides as LRRK2 kinase inhibitors

Compounds

Pyrimidine derivatives and their use as CB2 modulators

Pyrrolopyridine derivatives

Patents Applicationslast 30 patents

2-(BENZYLOXY) BENZAMIDES AS LRRK2 KINASE INHIBITORS

NOVEL COMPOUNDS

BENZOFURAN COMPOUNDS USEFUL IN THE TREATMENT OF CONDITIONS MEDIATED...

Pyrimidine Derivatives And Their Use As CB2 Modulators

2-(Phenylamino)-Pyrimidin-5-Amides As Cannabinoid 2 Receptors Modul...

Compounds

Pyridine Derivatives and Their Use as Cb2 Receptor Modulators

Pyrimidine Derivatives as Cannabinoid Receptor Modulators

Imidazopyridine Derivatives as Cannabinoid Receptor Ligands

Combination Of Cb2 Modulators And Pde4 Inhibitors For Use In Medicine

Pyrrolopyridine Derivatives

Pyridine derivatives as cb2 receptor modulators

Pyrimidine derivatives and their use as CB2 modulators

Pyrimidine compounds

Pyridine derivatives as cb2 receptor modulators